Directed Graphene-Based Nanoplatforms for Hyperthermia: Overcoming Multiple Drug Resistance

Angew Chem Int Ed Engl. 2018 Aug 27;57(35):11198-11202. doi: 10.1002/anie.201804291. Epub 2018 Aug 3.

Abstract

Multidrug resistance (MDR), which leads tumors resistance to traditional anticancer drugs, can cause the failure of chemotherapy treatments. Herein, we present a new way to overcome this problem using smart multifunctional graphene-based drug delivery systems which can target subcellular organelles and show synergistic hyperthermia and chemotherapy. Mitochondria-targeting ligands are conjugated onto the doxorubicin-loaded, polyglycerol-covered nanographene sheets to actively accumulate them inside the mitochondria after charge-mediated cellular internalization. Upon near-infrared (NIR) irradiation, adenosine triphosphate (ATP) synthesis and mitochondrial function were inhibited and doxorubicin released into the cellular interior. The hyperthermia-accelerated drug release led to a highly selective anticancer efficiency, confirmed by in vitro and in vivo experiments.

Keywords: drug delivery; graphene; hyperthermia; mitochondria; multidrug resistance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibiotics, Antineoplastic / administration & dosage
  • Antibiotics, Antineoplastic / pharmacokinetics
  • Antibiotics, Antineoplastic / therapeutic use*
  • Doxorubicin / administration & dosage
  • Doxorubicin / pharmacokinetics
  • Doxorubicin / therapeutic use*
  • Drug Carriers / chemistry
  • Drug Carriers / therapeutic use
  • Drug Delivery Systems*
  • Drug Resistance, Multiple
  • Drug Resistance, Neoplasm
  • Graphite / chemistry
  • Graphite / therapeutic use*
  • HeLa Cells
  • Humans
  • Hyperthermia, Induced / methods
  • Mice, Nude
  • Mitochondria / drug effects
  • Mitochondria / pathology
  • Nanostructures / chemistry
  • Nanostructures / therapeutic use*
  • Neoplasms / drug therapy
  • Neoplasms / pathology
  • Neoplasms / therapy*

Substances

  • Antibiotics, Antineoplastic
  • Drug Carriers
  • Graphite
  • Doxorubicin